Diabetes type2, Insulin Dependent Diabetes
Conditions
Keywords
Tip 2 Diyabet, Güvenli İlaç Kullanımı, Tedavi Algısı, İnsülin
Brief summary
This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.
Detailed description
Objective: The aim of this study was to examine the effects of individual insulin use training given to patients with Type 2 diabetes on safe drug administration, pain level and treatment perception, and to contribute to both national and international literature. Method: It was conducted between October 2022 and March 2023 as a randomized controlled study in a pre-test-post-test order to determine the effect of individual insulin use education given to patients with type 2 diabetes on safe drug administration, pain level and treatment perception. The data were collected by the researchers with the descriptive information form of the patients, the Insulin Administration Skill Observation Form, the Visual Analogue Scale and the Insulin Therapy Evaluation Scale. Data Collection: Face-to-face and individual interviews with patients who applied to the Internal Diseases and Endocrinology Polyclinic and Diabetes Nursing Polyclinics of a state hospital in a city located in the Southeastern Anatolia Region of Turkey, and who were hospitalized in the Internal Diseases, Endocrinology, Physical Therapy and Rehabilitation and Cardiology Services. collected using the method. A pilot study was not conducted before starting the study. Before the study, all patients were informed about the study and their verbal and written consents were obtained.
Interventions
None listed
Sponsors
Inonu University
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Patients included in the study; * 18 years and over Using insulin injections for at least six months or longer * Meeting the American Diabetes Association (ADA, 2021) diagnostic criteria for Type 2 diabetes * No communication and mental problems * Insulin injection made by himself or his family The patients who agreed to participate in the study.
Exclusion criteria
Patients excluded from the study; * Self or family member health personnel Those with advanced retinopathy, nephropathy, neuropathy * Diagnosed with type 1 diabetes * Pregnant or breastfeeding women * Patients who participated in another clinical trial concurrently or within 1 month prior to the start of the trial.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fırst follow - up survey | Fırst test-fırst applıcatıon both groups at the begınnıng of the research | Pretest data was obtained using the introductory information form, IASOF, VAS, and ITES. Patients were requested to apply their daily dose of insulin to themselves and patients' application skills were recorded by the researchers into IASOF as the 1st observation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Last test survey | 2 weeks after the fırst watch | Posttest data was obtained through the use of IASOF, VAS, and ITES. Patients were requested to apply their insulin dose of the day to themselves. Patients' insulin application skills were recorded by researchers into IASOF as the 2nd observation. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Durabılıty test for both groups | After 8 weeks, the follow-up test was done to both groups | Posttest data was obtained through the use of IASOF, VAS, and ITES. Patients were requested to apply their insulin dose of the day to themselves. Patients' insulin application skills were recorded by researchers into IASOF as the 3rd observation. |
Countries
Turkey (Türkiye)
Outcome results
None listed